The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The β -Adrenoceptor
Abstract
The human beta-adrenoceptor is a member of the seven-transmembrane family of receptors, encoded by a gene on chromosome 5. beta-Adrenoceptors have been classified into beta1, beta2, and beta3 subgroups, with beta2-receptors being widely distributed in the respiratory tract, particularly in airway smooth muscle. Intracellular signaling following beta2-adrenoceptor activation is largely affected through a trimeric Gs protein coupled to adenylate cyclase. Cyclic AMP (cAMP) induces airway relaxation through phosphorylation of muscle regulatory proteins and attenuation of cellular Ca2+ concentrations. Alternative cAMP-independent pathways involving activation of membrane maxi-K+ channels and coupling through Gi to the MAP kinase system have also been described. Site-directed mutagenesis has identified Asp 113 and Ser 204/207 within the third and fourth membrane domains as the active site of the beta2-receptor, critical for beta2-agonist binding and activity. beta2-Agonists have been characterized as those that directly activate the receptor (albuterol), those that are taken up into a membrane depot (formoterol), and those that interact with a receptor-specific auxiliary binding site (salmeterol). These differences in mechanism of action are reflected in the kinetics of airway smooth muscle relaxation and bronchodilation in patients with asthma. beta-Adrenoceptor desensitization associated with beta2-agonist activation is a consequence of phosphorylation by beta-ARK and uncoupling of the receptor from Gs following beta-arrestin binding, of internalization and recycling of the receptor through processes of sequestration and resensitization and downregulation, modulated by an effect on receptor gene expression. The degree of receptor desensitization appears to differ, depending on the cell or tissue type, and is reflected in the different profiles of clinical tolerance to chronic beta2-agonist therapy. A number of polymorphisms of the beta2-receptor have been described that appear to alter the behavior of the receptor following agonist exposure. These include Arg-Gly 16, Glu-Gln 27, and Thr-lle 164. The Gly 16 receptor downregulates to a greater extent and is associated with increased airway hyperreactivity, nocturnal symptoms, and more severe asthma. The Glu 27 form appears to protect against downregulation and is associated with less reactive airways. An individual can be homozygous or heterozygous for given polymorphisms, and large populations will have to be studied to determine their importance to the asthma phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy
Henderson, R., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., & Downing, K. H. (1990) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80271-2 · Cited by 2,980
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,270
Green, S. A., Turki, J., Innis, M., & Liggett, S. B. (1994) · Biochemistry · doi:10.1021/bi00198a006 · Cited by 772
Kobilka, B. K., Dixon, R. A., Frielle, T., Dohlman, H. G., Bolanowski, M. A., Sigal, I. S., Yang-Feng, T. L., Francke, U., Caron, M. G., & Lefkowitz, R. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.46 · Cited by 679
ADENYL CYCLASE AS AN ADRENERGIC RECEPTOR*
Robison, G. A., Butcher, R. W., & Sutherland, E. W. (1967) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1967.tb41239.x · Cited by 673
Mutations in the Gene Encoding for the β 2 -adrenergic Receptor in Normal and Asthmatic Subjects
Reihsaus, E., Innis, M., MacIntyre, N., & Liggett, S. B. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/8.3.334 · Cited by 617
Strader, C. D., Sigal, I. S., Candelore, M. R., Rands, E., Hill, W. S., & Dixon, R. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81509-0 · Cited by 534
Identification of Two Serine Residues Involved in Agonist Activation of the β-Adrenergic Receptor
Strader, C. D., Candelore, M. R., Hill, W. S., Sigal, I. S., & Dixon, R. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80035-7 · Cited by 523
Green, S. A., Turki, J., Bejarano, P., Hall, I. P., & Liggett, S. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7598936 · Cited by 439
Cited by
Cardiovascular Effects of β-Agonists in Patients With Asthma and COPD
Salpeter, S. R., Ormiston, T. M., & Salpeter, E. E. (2004) · Chest · doi:10.1378/chest.125.6.2309 · Cited by 560
Pharmacology and Therapeutics of Bronchodilators
Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004580 · Cited by 467
Salpeter, S. R., Buckley, N. S., Ormiston, T. M., & Salpeter, E. E. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-12-200606200-00126 · Cited by 461
Whalen, E. J., Foster, M. W., Matsumoto, A., Ozawa, K., Violin, J. D., Que, L. G., Nelson, C. D., Benhar, M., Keys, J. R., Rockman, H. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.02.046 · Cited by 311
De Matteis, R., Arch, J., Petroni, M., Ferrari, D., Cinti, S., & Stock, M. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802148 · Cited by 85
Metadata
- Authors
- JOHNSON, M.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-11-01
- Volume
- 158
- Issue
- supplement_2
- Pages
- S146-S153
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2127162896
- Cited by
- 397
- References
- 23
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The β -Adrenoceptor. https://app.cochat.ai/papers/10.1164/ajrccm.158.supplement_2.13tac110
- The paper
- JOHNSON, M. (1998). The β -Adrenoceptor. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.158.supplement_2.13tac110
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.